DUBAI, UAE, Dec. 8, 2025 -- AMBITIONS ENTERPRISE MANAGEMENT CO. L.L.C, (the "Company") (Nasdaq: AHMA), a United Arabic Emirates-based MICE (meetings, incentives, conferences, and exhibitions) and tourism services provider, today announced its unaudited financial results for the six months ended June 30, 2025. Financial Highlights for the Six Months Ended June 30, 2025 Revenue increased by 14% to US$9.7 million for the six months ended June 30, 2025, from US$8.5 million for the six months ended June 30, 2024. MICE management solution services revenue increased by 3
SINGAPORE, Dec. 8, 2025 -- ALR Technologies SG Ltd ("ALRT" or the "Company") (OTC: ALRTF), the diabetes management company, announces the successful completion of internal manufacturing testing on the GluCurve Pet CGM ("GluCurve") showing accuracy results comparative to the leading veterinary Blood Glucose Meter ("BGM") and scheduling of its relaunch into the Canadian market for January 2026. GluCurve is the first and only diabetic monitoring system built specifically for veterinary use on cats and dogs. A pet-friendly Continuous Glucose Monitor
INCHEON, South Korea, Dec. 8, 2025 -- Zymedi (CEO Sunghoon Kim) announced that the World Health Organization (WHO) has assigned rapaprutug as the International Nonproprietary Name (INN) for the company's first-in-class antibody therapy ZMA001, being developed as a treatment for pulmonary arterial hypertension (PAH). The assignment of the name rapaprutug (development code: ZMA001) marks a key global milestone and establishes a unified scientific identity for Zymedi's lead candidate as it advances through development. The antibody is currently being evaluated in an ongoing Phase 1 clinic
Submission marks a key regulatory milestone toward bringing SEER-calibrated, imaging-based risk assessment to U.S. screening programs SEOUL, South Korea, Dec. 8, 2025 -- Lunit (KRX:328130), a leading provider of AI for cancer diagnostics and precision oncology, today announced that it has submitted a 510(k) premarket notification to the U.S. Food and Drug Administration (FDA) for Lunit INSIGHT Risk, a mammography-based five-year breast cancer risk prediction model. Potential clearance is expected in 2026. Lunit INSIGHT Risk estimates a woman's five-year bre
NEW YORK, Dec. 8, 2025 -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins. NYSE Content Advisory: Pre-Market Update + ICE Data Show Home Affordability at Nearly Three-Year High Kristen Scholer delivers the pre-market update on December 8th Wall Street awaits the final interest rate decision of the year, with the Fed widely expected to cut borrowing costs by 0.25 percentage points on Wednesday at 2:00 PM ET, followed
ABU DHABI, UAE, Dec. 8, 2025 -- Yesterday, the McLaren Formula 1® Team's Lando Norris celebrated his first ever Drivers' Championship win at the Abu Dhabi Grand Prix whilst driving the MCL39 fan-designed livery. The VELO and the McLaren Formula 1® Team's livery design concept, co-created by nine superfans, features a series of bespoke icons, representing cherished fan memories and symbols, including an icon representing the papaya family and an icon representing back-to-back Constructors' Champions. Following this epic win, the team are celebrating a legendary 8
Munich brewery joins Audi's entry into Formula 1 Paulaner to bring celebratory and convivial culture to future Audi F1's global fanbase Long-term partnership to promote non-alcoholic Paulaner 0.0% INGOLSTADT and MUNICH, Germany, Dec. 8, 2025 -- The future Audi F1 Team and Paulaner Brewery have announced a long-term partnership, naming the Munich-based brewery an official supplier of the team. The agreement marks the start of a new chapter for Paulaner on the global motorsport stage. As the team joins the grid in 2026, this partnership will provide tangible opportunities to
SINGAPORE, Dec. 8, 2025 -- YY Group Holding Limited (NASDAQ: YYGH) ("YY Group" or the "Company"), a global leader in on-demand workforce solutions and integrated facilities management (IFM), today announced that it has added a Chief Product Officer (CPO) role to its executive team and appointed Mr. Eli Yu, an experienced product and technology leader, to the position. The establishment of the CPO role reflects the Company's commitment to accelerating product innovation and driving global growth and expansion. Mr. Yu will oversee end-to-end prod
SAN BERNARDINO, Calif., Dec. 8, 2025 -- Locksley Resources Limited (ASX: LKY/OTCQX: LKYRF/ADR: LKYLY) announced the successful completion of a heavily oversubscribed capital raising, securing firm commitments to raise approximately A$17 million via a placement of new shares at A$0.24 per share to Australian, US and international investors. Cornerstone investors in the placement included well established U.S. institutional investors, providing a strong endorsement of Locksley's strategy to deliver a fully integrated U.S. based "Mine to Market" critical minerals supply chain. M
[ 메디채널 황정호 기자 ] SGS-verified performance results underscore the need for reproducible, third-party testing across the emerging wearable robotics sector SHENZHEN, China, Dec. 8, 2025 -- Hypershell, the originator of the outdoor consumer exoskeleton category, today released the industry's first Consumer Exoskeleton Standards White Paper, establishing a foundational framework for transparent, reproducible, and scientifically rigorous evaluation of wearable mobility devices. The white paper includes newly published, independently conducted and Société Générale